<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36591299</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>12</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>05</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>The relationship between chronic immune response and neurodegenerative damage in long COVID-19.</ArticleTitle><Pagination><StartPage>1039427</StartPage><MedlinePgn>1039427</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1039427</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2022.1039427</ELocationID><Abstract><AbstractText>In the past two years, the world has faced the pandemic caused by the severe acute respiratory syndrome 2 coronavirus (SARS-CoV-2), which by August of 2022 has infected around 619 million people and caused the death of 6.55 million individuals globally. Although SARS-CoV-2 mainly affects the respiratory tract level, there are several reports, indicating that other organs such as the heart, kidney, pancreas, and brain can also be damaged. A characteristic observed in blood serum samples of patients suffering COVID-19 disease in moderate and severe stages, is a significant increase in proinflammatory cytokines such as interferon-&#x3b1; (IFN-&#x3b1;), interleukin-1&#x3b2; (IL-1&#x3b2;), interleukin-2 (IL-2), interleukin-6 (IL-6) and interleukin-18 (IL-18), as well as the presence of autoantibodies against interferon-&#x3b1; (IFN-&#x3b1;), interferon-&#x3bb; (IFN-&#x3bb;), C-C motif chemokine ligand 26 (CCL26), CXC motif chemokine ligand 12 (CXCL12), family with sequence similarity 19 (chemokine (C-C motif)-like) member A4 (FAM19A4), and C-C motif chemokine ligand 1 (CCL1). Interestingly, it has been described that the chronic cytokinemia is related to alterations of blood-brain barrier (BBB) permeability and induction of neurotoxicity. Furthermore, the generation of autoantibodies affects processes such as neurogenesis, neuronal repair, chemotaxis and the optimal microglia function. These observations support the notion that COVID-19 patients who survived the disease present neurological sequelae and neuropsychiatric disorders. The goal of this review is to explore the relationship between inflammatory and humoral immune markers and the major neurological damage manifested in post-COVID-19 patients.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Elizalde-D&#xed;az, Miranda-Narv&#xe1;ez, Mart&#xed;nez-Lazcano and Mart&#xed;nez-Mart&#xed;nez.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Elizalde-D&#xed;az</LastName><ForeName>Jos&#xe9; Pedro</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Laboratory of Cell Communication &amp; Extracellular Vesicles, Division of Basic Science, Instituto Nacional de Medicina Gen&#xf3;mica, Ciudad de M&#xe9;xico, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miranda-Narv&#xe1;ez</LastName><ForeName>Clara Leticia</ForeName><Initials>CL</Initials><AffiliationInfo><Affiliation>Laboratorio de Neurofarmacolog&#xed;a Molecular y Nanotecnolog&#xed;a, Instituto Nacional de Neurolog&#xed;a y Neurocirug&#xed;a Manuel Velasco Su&#xe1;rez, Ciudad de M&#xe9;xico, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mart&#xed;nez-Lazcano</LastName><ForeName>Juan Carlos</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Laboratorio de Neurofarmacolog&#xed;a Molecular y Nanotecnolog&#xed;a, Instituto Nacional de Neurolog&#xed;a y Neurocirug&#xed;a Manuel Velasco Su&#xe1;rez, Ciudad de M&#xe9;xico, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mart&#xed;nez-Mart&#xed;nez</LastName><ForeName>Eduardo</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Laboratory of Cell Communication &amp; Extracellular Vesicles, Division of Basic Science, Instituto Nacional de Medicina Gen&#xf3;mica, Ciudad de M&#xe9;xico, Mexico.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018925">Chemokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016898">Interferon-alpha</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015850">Interleukin-6</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008024">Ligands</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Front Immunol. 2023 Jun 01;14:1221642. doi: 10.3389/fimmu.2023.1221642</RefSource><PMID Version="1">37325637</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018925" MajorTopicYN="N">Chemokines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007109" MajorTopicYN="N">Immunity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016898" MajorTopicYN="N">Interferon-alpha</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015850" MajorTopicYN="N">Interleukin-6</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008024" MajorTopicYN="N">Ligands</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">autoantigens</Keyword><Keyword MajorTopicYN="N">autoantobodies</Keyword><Keyword MajorTopicYN="N">inflammatory response</Keyword><Keyword MajorTopicYN="N">long COVID syndrome</Keyword><Keyword MajorTopicYN="N">neurodegeneration</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>2</Day><Hour>4</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>12</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36591299</ArticleId><ArticleId IdType="pmc">PMC9800881</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2022.1039427</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>
WHO . WHO coronavirus (COVID-19) dashboard. Geneva, Switzerland: World Health Organization;  (2022). Available at: https://covid19.who.int/.</Citation></Reference><Reference><Citation>Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Diseases (2020) 20(5):533&#x2013;4. doi: 10.1016/S1473-3099(20)30120-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30120-1</ArticleId><ArticleId IdType="pmc">PMC7159018</ArticleId><ArticleId IdType="pubmed">32087114</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, et al. . Extrapulmonary manifestations of COVID-19. Nat Med (2020) 26(7):1017&#x2013;32. doi: 10.1038/s41591-020-0968-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0968-3</ArticleId><ArticleId IdType="pubmed">32651579</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. . Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in wuhan, China. JAMA Neurol (2020) 77(6):683&#x2013;90. doi: 10.1001/jamaneurol.2020.1127</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.1127</ArticleId><ArticleId IdType="pmc">PMC7149362</ArticleId><ArticleId IdType="pubmed">32275288</ArticleId></ArticleIdList></Reference><Reference><Citation>Paterson RW, Brown RL, Benjamin L, Nortley R, Wiethoff S, Bharucha T, et al. . The emerging spectrum of COVID-19 neurology: Clinical, radiological and laboratory findings. Brain (2020) 143(10):3104&#x2013;20. doi: 10.1093/brain/awaa240</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa240</ArticleId><ArticleId IdType="pmc">PMC7454352</ArticleId><ArticleId IdType="pubmed">32637987</ArticleId></ArticleIdList></Reference><Reference><Citation>Dietrich A, Stete K, Hilger H, G&#xf6;tz V, Biever P, Hosp J, et al. . Complaints and clinical findings six months after COVID-19: Outpatient follow-up at the university medical center freiburg. Deutsche Medizinische Wochenschrift (2021) 146(17):e65&#x2013;73. doi:&#xa0;10.1055/a-1546-4291</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/a-1546-4291</ArticleId><ArticleId IdType="pubmed">34425627</ArticleId></ArticleIdList></Reference><Reference><Citation>
WHO . A clinical case definition of post COVID-19 condition by a Delphi consensus. Geneva, Switzerland: World Health Organization;  (2021). Available at: https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1.</Citation></Reference><Reference><Citation>
WHO . Coronavirus disease (COVID-19): Post COVID-19 condition. Geneva, Switzerland: World Healt Organization;  (2021). Available at: https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-(covid-19)-post-covid-19-condition#:~:text=People%20wth%20post%20COVID%2D19,as%20work%20or%20household%20chores.</Citation></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F. For the gemelli against c-P-ACSG. persistent symptoms in patients after acute COVID-19. JAMA (2020) 324(6):603&#x2013;5. doi:&#xa0;10.1001/jama.2020.1260313</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.1260313</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde MW, Kim SS, Lindsell CJ, Billig Rose E, Shapiro NI, Files DC, et al. . Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network - united states, march-June 2020. MMWR Morb Mortal Wkly Rep (2020) 69(30):993&#x2013;8. doi: 10.15585/mmwr.mm6930e1</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6930e1</ArticleId><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. . 6-month consequences of COVID-19 in patients discharged from hospital: A cohort study. Lancet (2021) 397(10270):220&#x2013;32. doi: 10.1016/S0140-6736(20)32656-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold DT, Hamilton FW, Milne A, Morley AJ, Viner J, Attwood M, et al. . Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: Results from a prospective UK cohort. Thorax (2021) 76(4):399&#x2013;401. doi: 10.1136/thoraxjnl-2020-216086</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-216086</ArticleId><ArticleId IdType="pmc">PMC7716340</ArticleId><ArticleId IdType="pubmed">33273026</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi-Pooya AA, Akbari A, Emami A, Lotfi M, Rostamihosseinkhani M, Nemati H, et al. . Risk factors associated with long COVID syndrome: A retrospective study. Iranian J Med Sci (2021) 46(6):428.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8611223</ArticleId><ArticleId IdType="pubmed">34840383</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Gennaro F, Belati A, Tulone O, Diella L, Bavaro DF, Bonica R, et al. . Long covid: A systematic review and meta-analysis of 120,970 patients. Intern Emerg Med (2022). doi:&#xa0;10.1007/s11739-022-03164-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11739-022-03164-w</ArticleId><ArticleId IdType="pmc">PMC9709360</ArticleId><ArticleId IdType="pubmed">36449260</ArticleId></ArticleIdList></Reference><Reference><Citation>Spudich S, Nath A. Nervous system consequences of COVID-19. Science (2022) 375(6578):267&#x2013;9. doi:&#xa0;10.1126/science.abm2052</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abm2052</ArticleId><ArticleId IdType="pubmed">35050660</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang TZ, Sell J, Weiss D, Lall R. COVID-19 presenting as anosmia and dysgeusia in new York city emergency departments. medRxiv (2020) 2020.07.06.20147751. doi:&#xa0;10.1101/2020.07.06.20147751</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.07.06.20147751</ArticleId></ArticleIdList></Reference><Reference><Citation>Zazhytska M, Kodra A, Hoagland DA, Fullard JF, Shayya H, Omer A, et al. . Disruption of nuclear architecture as a cause of COVID-19 induced anosmia. bioRxiv (2021) 2021.02.09.430314. doi:&#xa0;10.1101/2021.02.09.430314</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.02.09.430314</ArticleId><ArticleId IdType="pmc">PMC8808699</ArticleId><ArticleId IdType="pubmed">35180380</ArticleId></ArticleIdList></Reference><Reference><Citation>Varatharaj A, Thomas N, Ellul MA, Davies NWS, Pollak TA, Tenorio EL, et al. . Neurological and neuropsychiatric complications of COVID-19 in 153 patients: A UK-wide surveillance study. Lancet Psychiatry (2020) 7(10):875&#x2013;82. doi:&#xa0;10.1016/S2215-0366(20)30287-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30287-X</ArticleId><ArticleId IdType="pmc">PMC7316461</ArticleId><ArticleId IdType="pubmed">32593341</ArticleId></ArticleIdList></Reference><Reference><Citation>Pezzini A, Padovani A. Lifting the mask on neurological manifestations of COVID-19. Nat Rev Neurol (2020) 16(11):636&#x2013;44. doi: 10.1038/s41582-020-0398-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-020-0398-3</ArticleId><ArticleId IdType="pmc">PMC7444680</ArticleId><ArticleId IdType="pubmed">32839585</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry (2021) 8(5):416&#x2013;27. doi: 10.1016/S2215-0366(21)00084-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(21)00084-5</ArticleId><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. . Post-acute COVID-19 syndrome. Nat Med (2021) 27(4):601&#x2013;15. doi: 10.1038/s41591-021-01283-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed H, Patel K, Greenwood DC, Halpin S, Lewthwaite P, Salawu A, et al. . Long-term clinical outcomes in survivors of severe acute respiratory syndrome and middle East respiratory syndrome coronavirus outbreaks after hospitalisation or ICU admission: A systematic review and meta-analysis. J Rehabil Med (2020) 52(5):1&#x2013;11. doi: 10.2340/16501977-2694</Citation><ArticleIdList><ArticleId IdType="doi">10.2340/16501977-2694</ArticleId><ArticleId IdType="pubmed">32449782</ArticleId></ArticleIdList></Reference><Reference><Citation>Moldofsky H, Patcai J. Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study. BMC neurol (2011) 11(1):1&#x2013;7. doi: 10.1186/1471-2377-11-37</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2377-11-37</ArticleId><ArticleId IdType="pmc">PMC3071317</ArticleId><ArticleId IdType="pubmed">21435231</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarius S, Pache F, K&#xf6;rtvelyessy P, Jel&#x10d;i&#x107; I, Stettner M, Franciotta D, et al. . Cerebrospinal fluid findings in COVID-19: a multicenter study of 150 lumbar punctures in 127 patients. J neuroinflammation (2022) 19(1):1&#x2013;33. doi: 10.1186/s12974-021-02339-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-021-02339-0</ArticleId><ArticleId IdType="pmc">PMC8771621</ArticleId><ArticleId IdType="pubmed">35057809</ArticleId></ArticleIdList></Reference><Reference><Citation>Desforges M, Le Coupanec A, Dubeau P, Bourgouin A, Lajoie L, Dub&#xe9; M, et al. . Human coronaviruses and other respiratory viruses: Underestimated opportunistic pathogens of the central nervous system? viruses (2019) 12(1):14. doi: 10.3390/v12010014</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v12010014</ArticleId><ArticleId IdType="pmc">PMC7020001</ArticleId><ArticleId IdType="pubmed">31861926</ArticleId></ArticleIdList></Reference><Reference><Citation>Netland J, Meyerholz DK, Moore S, Cassell M, Perlman S. Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J virol (2008) 82(15):7264&#x2013;75. doi: 10.1128/JVI.00737-08</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00737-08</ArticleId><ArticleId IdType="pmc">PMC2493326</ArticleId><ArticleId IdType="pubmed">18495771</ArticleId></ArticleIdList></Reference><Reference><Citation>Li K, Wohlford-Lenane C, Perlman S, Zhao J, Jewell AK, Reznikov LR, et al. . Middle East respiratory syndrome coronavirus causes multiple organ damage and lethal disease in mice transgenic for human dipeptidyl peptidase 4. J Infect diseases (2016) 213(5):712&#x2013;22. doi: 10.1093/infdis/jiv499</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiv499</ArticleId><ArticleId IdType="pmc">PMC4747621</ArticleId><ArticleId IdType="pubmed">26486634</ArticleId></ArticleIdList></Reference><Reference><Citation>De Santis G. SARS-CoV-2: a new virus but a familiar inflammation brain pattern. Brain Behav Immun (2020) 87:95. doi: 10.1016/j.bbi.2020.04.066</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.04.066</ArticleId><ArticleId IdType="pmc">PMC7184990</ArticleId><ArticleId IdType="pubmed">32353523</ArticleId></ArticleIdList></Reference><Reference><Citation>Desforges M, Le Coupanec A, Stodola JK, Meessen-Pinard M, Talbot PJ. Human coronaviruses: Viral and cellular factors involved in neuroinvasiveness and neuropathogenesis. Virus Res (2014) 194:145&#x2013;58. doi: 10.1016/j.virusres.2014.09.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2014.09.011</ArticleId><ArticleId IdType="pmc">PMC7114389</ArticleId><ArticleId IdType="pubmed">25281913</ArticleId></ArticleIdList></Reference><Reference><Citation>Philippens IHCHM, B&#xf6;sz&#xf6;rm&#xe9;nyi KP, Wubben JA, Fagrouch ZC, van Driel N, Mayenburg AQ, et al. . SARS-CoV-2 causes brain inflammation and induces lewy body formation in macaques. bioRxiv (2021) 2021:02.23.432474. doi: 10.1101/2021.02.23.432474</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.02.23.432474</ArticleId></ArticleIdList></Reference><Reference><Citation>Meinhardt J, Radke J, Dittmayer C, Franz J, Thomas C, Mothes R, et al. . Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat Neurosci (2021) 24(2):168&#x2013;75. doi: 10.1038/s41593-020-00758-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-00758-5</ArticleId><ArticleId IdType="pubmed">33257876</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S, Han Y, Yang L, Kim T, Nair M, Harschnitz O, et al. . SARS-CoV-2 infection causes dopaminergic neuron senescence. Res Sq; (2021) p. rs&#x2013;51346. doi:&#xa0;10.21203/rs.3.rs-513461/v1</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-513461/v1</ArticleId><ArticleId IdType="pmc">PMC10843182</ArticleId><ArticleId IdType="pubmed">38237586</ArticleId></ArticleIdList></Reference><Reference><Citation>Chertow D, Stein S, Ramelli S, Grazioli A, Chung J-Y, Singh M, et al. . SARS-CoV-2 infection and persistence throughout the human body and brain. Res Sq (2021). doi: 10.21203/rs.3.rs-1139035/v1</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-1139035/v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Puelles VG, L&#xfc;tgehetmann M, Lindenmeyer MT, Sperhake JP, Wong MN, Allweiss L, et al. . Multiorgan and renal tropism of SARS-CoV-2. New Engl J Med (2020) 383(6):590&#x2013;2. doi: 10.1056/NEJMc2011400</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2011400</ArticleId><ArticleId IdType="pmc">PMC7240771</ArticleId><ArticleId IdType="pubmed">32402155</ArticleId></ArticleIdList></Reference><Reference><Citation>Brann DH, Tsukahara T, Weinreb C, Lipovsek M, Van den Berge K, Gong B, et al. . Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia. Sci Adv (2020) 6(31):eabc5801. doi: 10.1126/sciadv.abc5801</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abc5801</ArticleId><ArticleId IdType="pmc">PMC10715684</ArticleId><ArticleId IdType="pubmed">32937591</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper KW, Brann DH, Farruggia MC, Bhutani S, Pellegrino R, Tsukahara T, et al. . COVID-19 and the chemical senses: Supporting players take center stage. Neuron (2020) 107(2):219&#x2013;33. doi: 10.1016/j.neuron.2020.06.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2020.06.032</ArticleId><ArticleId IdType="pmc">PMC7328585</ArticleId><ArticleId IdType="pubmed">32640192</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G, Lee S, Alfaro-Almagro F, Arthofer C, Wang C, McCarthy P, et al. . SARS-CoV-2 is associated with changes in brain structure in UK biobank. Nature (2022) 604(7907):697&#x2013;707. doi: 10.1038/s41586-022-04569-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04569-5</ArticleId><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Benz F, Liebner S. Structure and function of the blood&#x2013;brain barrier (BBB). Handb Exp Pharmacol (2022) 273:3&#x2013;31. doi:&#xa0;10.1007/164_2020_404</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/164_2020_404</ArticleId><ArticleId IdType="pubmed">33249527</ArticleId></ArticleIdList></Reference><Reference><Citation>Harden LM, Kent S, Pittman QJ, Roth J. Fever and sickness behavior: Friend or foe? Brain behavior Immun (2015) 50:322&#x2013;33. doi: 10.1016/j.bbi.2015.07.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2015.07.012</ArticleId><ArticleId IdType="pubmed">26187566</ArticleId></ArticleIdList></Reference><Reference><Citation>Varatharaj A, Galea I. The blood-brain barrier in systemic inflammation. Brain Behav Immun (2017) 60:1&#x2013;12. doi: 10.1016/j.bbi.2016.03.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2016.03.010</ArticleId><ArticleId IdType="pubmed">26995317</ArticleId></ArticleIdList></Reference><Reference><Citation>Galea I. The blood&#x2013;brain barrier in systemic infection and inflammation. Cell Mol Immunol (2021) 18(11):2489&#x2013;501. doi: 10.1038/s41423-021-00757-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-021-00757-x</ArticleId><ArticleId IdType="pmc">PMC8481764</ArticleId><ArticleId IdType="pubmed">34594000</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee MH, Perl DP, Steiner J, Pasternack N, Li W, Maric D, et al. . Neurovascular injury with complement activation and inflammation in COVID-19. Brain (2022) 145(7):2555&#x2013;68. doi: 10.1093/brain/awac151</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awac151</ArticleId><ArticleId IdType="pmc">PMC9278212</ArticleId><ArticleId IdType="pubmed">35788639</ArticleId></ArticleIdList></Reference><Reference><Citation>Haidar MA, Shakkour Z, Reslan MA, Al-Haj N, Chamoun P, Habashy K, et al. . SARS-CoV-2 involvement in central nervous system tissue damage. Neural regeneration Res (2022) 17(6):1228. doi:&#xa0;10.4103/1673-5374.327323</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.327323</ArticleId><ArticleId IdType="pmc">PMC8643043</ArticleId><ArticleId IdType="pubmed">34782556</ArticleId></ArticleIdList></Reference><Reference><Citation>Farhadian S, Glick LR, Vogels CBF, Thomas J, Chiarella J, Casanovas-Massana A, et al. . Acute encephalopathy with elevated CSF inflammatory markers as the initial presentation of COVID-19. BMC Neurol (2020) 20(1):248. doi: 10.1186/s12883-020-01812-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12883-020-01812-2</ArticleId><ArticleId IdType="pmc">PMC7301053</ArticleId><ArticleId IdType="pubmed">32552792</ArticleId></ArticleIdList></Reference><Reference><Citation>Bodro M, Compta Y, Llans&#xf3; L, Esteller D, Doncel-Moriano A, Mesa A, et al. . Increased CSF levels of IL-1&#x3b2;, IL-6, and ACE in SARS-CoV-2&#x2013;associated encephalitis. Neurol - Neuroimmunol Neuroinflammation (2020) 7(5):e821. doi:&#xa0;10.1212/NXI.0000000000000821</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000000821</ArticleId><ArticleId IdType="pmc">PMC7357418</ArticleId><ArticleId IdType="pubmed">32611761</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrin P, Collongues N, Baloglu S, Bedo D, Bassand X, Lavaux T, et al. . Cytokine release syndrome-associated encephalopathy in patients with COVID-19. Eur J Neurol (2021) 28(1):248&#x2013;58. doi:&#xa0;10.1111/ene.14491</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14491</ArticleId><ArticleId IdType="pmc">PMC7461405</ArticleId><ArticleId IdType="pubmed">32853434</ArticleId></ArticleIdList></Reference><Reference><Citation>Pilotto A, Masciocchi S, Volonghi I, De Giuli V, Caprioli F, Mariotto S, et al. . SARS-CoV-2 encephalitis is a cytokine release syndrome: Evidences from cerebrospinal fluid analyses. Clin Infect Dis (2021) 73(9):e3019&#x2013;26. doi:&#xa0;10.1093/cid/ciaa1933</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1933</ArticleId><ArticleId IdType="pmc">PMC7799260</ArticleId><ArticleId IdType="pubmed">33395482</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-Casta&#xf1;eda A, Lu P, Geraghty AC, Song E, Lee M-H, Wood J, et al. . Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation. Cell (2022) 185(14):2452&#x2013;68.e16. doi:&#xa0;10.1016/j.cell.2022.06.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.06.008</ArticleId><ArticleId IdType="pmc">PMC9189143</ArticleId><ArticleId IdType="pubmed">35768006</ArticleId></ArticleIdList></Reference><Reference><Citation>Acosta-Ampudia Y, Monsalve DM, Rojas M, Rodr&#xed;guez Y, Zapata E, Ram&#xed;rez-Santana C, et al. . Persistent autoimmune activation and proinflammatory state in post-coronavirus disease 2019 syndrome. J Infect diseases (2022) 225(12):2155&#x2013;62. doi:&#xa0;10.1093/infdis/jiac017</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac017</ArticleId><ArticleId IdType="pmc">PMC8903340</ArticleId><ArticleId IdType="pubmed">35079804</ArticleId></ArticleIdList></Reference><Reference><Citation>Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, et al. . Endothelial cell infection and endotheliitis in COVID-19. Lancet (2020) 395(10234):1417&#x2013;8. doi:&#xa0;10.1093/infdis/jiac017</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac017</ArticleId><ArticleId IdType="pmc">PMC7172722</ArticleId><ArticleId IdType="pubmed">32325026</ArticleId></ArticleIdList></Reference><Reference><Citation>Aw E, Zhang Y, Carroll M. Microglial responses to peripheral type 1 interferon. J Neuroinflammation (2020) 17(1):340. doi: 10.1186/s12974-020-02003-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-020-02003-z</ArticleId><ArticleId IdType="pmc">PMC7659169</ArticleId><ArticleId IdType="pubmed">33183319</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J, Liu X, Zhong Y. Interleukin-17A: The key cytokine in neurodegenerative diseases. Front Aging Neurosci (2020) 12:566922. doi: 10.3389/fnagi.2020.566922</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2020.566922</ArticleId><ArticleId IdType="pmc">PMC7550684</ArticleId><ArticleId IdType="pubmed">33132897</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Filippo M, Mancini A, Bellingacci L, Gaetani L, Mazzocchetti P, Zelante T, et al. . Interleukin-17 affects synaptic plasticity and cognition in an experimental model of multiple sclerosis. Cell Rep (2021) 37(10):110094. doi: 10.1016/j.celrep.2021.110094</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.110094</ArticleId><ArticleId IdType="pubmed">34879272</ArticleId></ArticleIdList></Reference><Reference><Citation>Drexhage RC, van der Heul-Nieuwenhuijsen L, Padmos RC, van Beveren N, Cohen D, Versnel MA, et al. . Inflammatory gene expression in monocytes of patients with schizophrenia: Overlap and difference with bipolar disorder. a study in naturalistically treated patients. Int J Neuropsychopharmacol (2010) 13(10):1369&#x2013;81. doi: 10.1017/S1461145710000799</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1461145710000799</ArticleId><ArticleId IdType="pubmed">20633309</ArticleId></ArticleIdList></Reference><Reference><Citation>Esp&#xed;ndola OM, Gomes YCP, Brand&#xe3;o CO, Torres RC, Siqueira M, Soares CN, et al. . Inflammatory cytokine patterns associated with neurological diseases in coronavirus disease 2019. Ann Neurol (2021) 89(5):1041&#x2013;5. doi: 10.1002/ana.26041</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.26041</ArticleId><ArticleId IdType="pmc">PMC8014707</ArticleId><ArticleId IdType="pubmed">33547819</ArticleId></ArticleIdList></Reference><Reference><Citation>Konsman JP. Cytokines in the brain and neuroinflammation: We didn&#x2019;t starve the fire! Pharmaceuticals (2022) 15(2):140. doi: 10.3390/ph15020140</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph15020140</ArticleId><ArticleId IdType="pmc">PMC8878213</ArticleId><ArticleId IdType="pubmed">35215252</ArticleId></ArticleIdList></Reference><Reference><Citation>Stuart MJ, Singhal G, Baune BT. Systematic review of the neurobiological relevance of chemokines to psychiatric disorders. Front Cell Neurosci (2015) 9:357. doi: 10.3389/fncel.2015.00357</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2015.00357</ArticleId><ArticleId IdType="pmc">PMC4564736</ArticleId><ArticleId IdType="pubmed">26441528</ArticleId></ArticleIdList></Reference><Reference><Citation>Szabo A, O&#x2019;Connell KS, Ueland T, Sheikh MA, Agartz I, Andreou D, et al. . Increased circulating IL-18 levels in severe mental disorders indicate systemic inflammasome activation. Brain Behav Immun (2022) 99:299&#x2013;306. doi: 10.1016/j.bbi.2021.10.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.10.017</ArticleId><ArticleId IdType="pubmed">34758379</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams JA, Burgess S, Suckling J, Lalousis PA, Batool F, Griffiths SL, et al. . Inflammation and brain structure in schizophrenia and other neuropsychiatric disorders: A mendelian randomization study. JAMA Psychiatry (2022) 79(5):498&#x2013;507. doi: 10.1001/jamapsychiatry.2022.0407</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2022.0407</ArticleId><ArticleId IdType="pmc">PMC8968718</ArticleId><ArticleId IdType="pubmed">35353173</ArticleId></ArticleIdList></Reference><Reference><Citation>Alboni S, Cervia D, Sugama S, Conti B. Interleukin 18 in the CNS. J neuroinflammation (2010) 7(1):1&#x2013;12. doi: 10.1186/1742-2094-7-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-7-9</ArticleId><ArticleId IdType="pmc">PMC2830964</ArticleId><ArticleId IdType="pubmed">20113500</ArticleId></ArticleIdList></Reference><Reference><Citation>Azizi G, Khannazer N, Mirshafiey A. The potential role of chemokines in alzheimer&#x2019;s disease pathogenesis. Am J Alzheimer's Dis Other Dementias&#xae; (2014) 29(5):415&#x2013;25. doi:&#xa0;10.1177/1533317513518651</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1533317513518651</ArticleId><ArticleId IdType="pmc">PMC10852600</ArticleId><ArticleId IdType="pubmed">24408754</ArticleId></ArticleIdList></Reference><Reference><Citation>Marciniak E, Faivre E, Dutar P, Alves Pires C, Demeyer D, Caillierez R, et al. . The chemokine MIP-1&#x3b1;/CCL3 impairs mouse hippocampal synaptic transmission, plasticity and memory. Sci Rep (2015) 5(1):15862. doi:&#xa0;10.1038/srep15862</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep15862</ArticleId><ArticleId IdType="pmc">PMC4625372</ArticleId><ArticleId IdType="pubmed">26511387</ArticleId></ArticleIdList></Reference><Reference><Citation>Sumita Y, Murakawa Y, Sugiura T, Wada Y, Nagai A, Yamaguchi S. Elevated BAFF levels in the cerebrospinal fluid of patients with neuro-beh&#xe7;et&#x2019;s disease: BAFF is correlated with progressive dementia and psychosis. Scandinavian J Immunol (2012) 75(6):633&#x2013;40. doi:&#xa0;10.1111/j.1365-3083.2012.02694.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-3083.2012.02694.x</ArticleId><ArticleId IdType="pmc">PMC3437506</ArticleId><ArticleId IdType="pubmed">22340436</ArticleId></ArticleIdList></Reference><Reference><Citation>Nesterova IV, Kovaleva SV, Malinovskaya VV, Chudilova GA, Rusinova TV. Congenital and acquired interferonopathies: Differentiated approaches to interferon therapy. Innate Immun Health Dis (2020). doi:&#xa0;10.5772/intechopen.91723.</Citation><ArticleIdList><ArticleId IdType="doi">10.5772/intechopen.91723.</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho LA, Bergink V, Sumaski L, Wijkhuijs J, Hoogendijk WJ, Birkenhager TK, et al. . Inflammatory activation is associated with a reduced glucocorticoid receptor alpha/beta expression ratio in monocytes of inpatients with melancholic major depressive disorder. Trans Psychiatry (2014) 4(1):e344&#x2013;e. doi:&#xa0;10.1038/tp.2013.118</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/tp.2013.118</ArticleId><ArticleId IdType="pmc">PMC3905228</ArticleId><ArticleId IdType="pubmed">24424390</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghoryani M, Faridhosseini F, Talaei A, Faridhosseini R, Tavakkol-Afshari J, Moghaddam MD, et al. . Gene expression pattern of CCL2, CCL3, and CXCL8 in patients with bipolar disorder. J Res Med Sciences: Off J Isfahan Univ Med Sci (2019) 24:45. doi:&#xa0;10.4103/jrms.JRMS_763_18</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/jrms.JRMS_763_18</ArticleId><ArticleId IdType="pmc">PMC6540773</ArticleId><ArticleId IdType="pubmed">31160912</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoseth EZ, Ueland T, Dieset I, Birnbaum R, Shin JH, Kleinman JE, et al. . A study of TNF pathway activation in schizophrenia and bipolar disorder in plasma and brain tissue. Schizophr Bulletin (2017) 43(4):881&#x2013;90. doi: 10.1093/schbul/sbw183</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/schbul/sbw183</ArticleId><ArticleId IdType="pmc">PMC5515106</ArticleId><ArticleId IdType="pubmed">28049760</ArticleId></ArticleIdList></Reference><Reference><Citation>Ivanovska M, Abdi Z, Murdjeva M, Macedo D, Maes A, Maes M. CCL-11 or eotaxin-1: an immune marker for ageing and accelerated ageing in neuro-psychiatric disorders. Pharmaceuticals (2020) 13(9):230. doi: 10.3390/ph13090230</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph13090230</ArticleId><ArticleId IdType="pmc">PMC7558796</ArticleId><ArticleId IdType="pubmed">32887304</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuzior H, Fiebich BL, Yousif NM, Saliba SW, Ziegler C, Nickel K, et al. . Increased IL-8 concentrations in the cerebrospinal fluid of patients with unipolar depression. Compr Psychiatry (2020) 102:152196. doi: 10.1016/j.comppsych.2020.152196</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.comppsych.2020.152196</ArticleId><ArticleId IdType="pubmed">32927367</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanz TA, Reinhart V, Sheehan MJ, Rizzo SJS, Bove SE, James LC, et al. . Postmortem transcriptional profiling reveals widespread increase in inflammation in schizophrenia: A comparison of prefrontal cortex, striatum, and hippocampus among matched tetrads of controls with subjects diagnosed with schizophrenia, bipolar or major depressive disorder. Trans Psychiatry (2019) 9(1):151. doi: 10.1038/s41398-019-0492-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41398-019-0492-8</ArticleId><ArticleId IdType="pmc">PMC6533277</ArticleId><ArticleId IdType="pubmed">31123247</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q, Roy B, Turecki G, Shelton RC, Dwivedi Y. Role of complex epigenetic switching in tumor necrosis factor-&#x3b1; upregulation in the prefrontal cortex of suicide subjects. Am J Psychiatry (2018) 175(3):262&#x2013;74. doi: 10.1176/appi.ajp.2017.16070759</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.ajp.2017.16070759</ArticleId><ArticleId IdType="pmc">PMC5832541</ArticleId><ArticleId IdType="pubmed">29361849</ArticleId></ArticleIdList></Reference><Reference><Citation>Engh JA, Ueland T, Agartz I, Andreou D, Aukrust P, Boye B, et al. . Plasma levels of the cytokines b cell-activating factor (BAFF) and a proliferation-inducing ligand (APRIL) in schizophrenia, bipolar, and major depressive disorder: A cross sectional, multisite study. Schizophr Bulletin (2022) 48(1):37&#x2013;46. doi: 10.1093/schbul/sbab106</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/schbul/sbab106</ArticleId><ArticleId IdType="pmc">PMC8781325</ArticleId><ArticleId IdType="pubmed">34499169</ArticleId></ArticleIdList></Reference><Reference><Citation>Bedrossian N, Haidar M, Fares J, Kobeissy FH, Fares Y. Inflammation and elevation of interleukin-12p40 in patients with schizophrenia. Front Mol Neurosci (2016) 9:16. doi: 10.3389/fnmol.2016.00016</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2016.00016</ArticleId><ArticleId IdType="pmc">PMC4801873</ArticleId><ArticleId IdType="pubmed">27047333</ArticleId></ArticleIdList></Reference><Reference><Citation>Bido S, Muggeo S, Massimino L, Marzi MJ, Giannelli SG, Melacini E, et al. . Microglia-specific overexpression of &#x3b1;-synuclein leads to severe dopaminergic neurodegeneration by phagocytic exhaustion and oxidative toxicity. Nat Commun (2021) 12(1):6237. doi: 10.1038/s41467-021-26519-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-26519-x</ArticleId><ArticleId IdType="pmc">PMC8556263</ArticleId><ArticleId IdType="pubmed">34716339</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhaiban S, Al-Ani M, Elemam NM, Maghazachi AA. Targeting chemokines and chemokine receptors in multiple sclerosis and experimental autoimmune encephalomyelitis. J Inflammation Res (2020) 13:619. doi: 10.2147/JIR.S270872</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JIR.S270872</ArticleId><ArticleId IdType="pmc">PMC7532903</ArticleId><ArticleId IdType="pubmed">33061527</ArticleId></ArticleIdList></Reference><Reference><Citation>Doron H, Amer M, Ershaid N, Blazquez R, Shani O, Lahav TG, et al. . Inflammatory activation of astrocytes facilitates melanoma brain tropism via the CXCL10-CXCR3 signaling axis. Cell Rep (2019) 28(7):1785&#x2013;98.e6. doi: 10.1016/j.celrep.2019.07.033</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.07.033</ArticleId><ArticleId IdType="pubmed">31412247</ArticleId></ArticleIdList></Reference><Reference><Citation>Estevao C, Bowers CE, Luo D, Sarker M, Hoeh AE, Frudd K, et al. . CCL4 induces inflammatory signalling and barrier disruption in the neurovascular endothelium. Brain Behavior Immun - Health (2021) 18:100370. doi: 10.1016/j.bbih.2021.100370</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2021.100370</ArticleId><ArticleId IdType="pmc">PMC8560974</ArticleId><ArticleId IdType="pubmed">34755124</ArticleId></ArticleIdList></Reference><Reference><Citation>Hajiannasab R. Investigating the extent of CCL4 and CCL5 chemokine as well as IL17 and IL23 cytokine gene expression in the patients afflicted with multiple sclerosis. Int J Clin Med (2016) 7(9):598&#x2013;607. doi: 10.4236/ijcm.2016.79066</Citation><ArticleIdList><ArticleId IdType="doi">10.4236/ijcm.2016.79066</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrella O, Guerriero M, Izzo E, Soscia M, Carrieri PB. Interleukin-6 and granulocyte macrophage-CSF in the cerebrospinal fluid from HIV infected subjects with involvement of the central nervous system. Arquivos neuro-psiquiatria (1992) 50:180&#x2013;2. doi: 10.1590/S0004-282X1992000200008</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S0004-282X1992000200008</ArticleId><ArticleId IdType="pubmed">1308387</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakr NM, Hashim NA, Awad A, Sarhan A-A. Association between interleukin-18 promoter polymorphisms and risk of ischemic stroke: A case-control study. Egyptian J Med Hum Genet (2018) 19(1):13&#x2013;8. doi: 10.1016/j.ejmhg.2017.08.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmhg.2017.08.014</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyon A. CXCL12 chemokine and its receptors as major players in the interactions between immune and nervous systems. Front Cell Neurosci (2014) 8:65. doi: 10.3389/fncel.2014.00065</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2014.00065</ArticleId><ArticleId IdType="pmc">PMC3944789</ArticleId><ArticleId IdType="pubmed">24639628</ArticleId></ArticleIdList></Reference><Reference><Citation>Muhammad M. Tumor necrosis factor alpha: A major cytokine of brain neuroinflammation. Cytokines (2019) in Behzadi P. (eds.) (London: Cytokines, IntechOpen; ) 861231. doi:&#xa0;10.5772/intechopen.85476</Citation><ArticleIdList><ArticleId IdType="doi">10.5772/intechopen.85476</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L, Wang M, Guo YY, Sun T, Li YJ, Yang Q, et al. . Systemic inflammation induces anxiety disorder through CXCL12/CXCR4 pathway. Brain Behav Immun (2016) 56:352&#x2013;62. doi: 10.1016/j.bbi.2016.03.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2016.03.001</ArticleId><ArticleId IdType="pubmed">26952745</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhamoon MS, Thaler A, Gururangan K, Kohli A, Sisniega D, Wheelwright D, et al. . Acute cerebrovascular events with COVID-19 infection. Stroke (2021) 52(1):48&#x2013;56. doi: 10.1161/STROKEAHA.120.031668</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.120.031668</ArticleId><ArticleId IdType="pubmed">33280551</ArticleId></ArticleIdList></Reference><Reference><Citation>DiSabato DJ, Quan N, Godbout JP. Neuroinflammation: The devil is in the details. J Neurochem (2016) 139(S2):136&#x2013;53. doi: 10.1111/jnc.13607</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.13607</ArticleId><ArticleId IdType="pmc">PMC5025335</ArticleId><ArticleId IdType="pubmed">26990767</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Xu X, Chen Z, Duan J, Hashimoto K, Yang L, et al. . Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun (2020) 87:18&#x2013;22. doi: 10.1016/j.bbi.2020.03.031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.03.031</ArticleId><ArticleId IdType="pmc">PMC7146689</ArticleId><ArticleId IdType="pubmed">32240762</ArticleId></ArticleIdList></Reference><Reference><Citation>Spence JD, de Freitas GR, Pettigrew LC, Ay H, Liebeskind DS, Kase CS, et al. . Mechanisms of stroke in COVID-19. Cerebrovasc Dis (2020) 49(4):451&#x2013;8. doi: 10.1159/000509581</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000509581</ArticleId><ArticleId IdType="pmc">PMC7445374</ArticleId><ArticleId IdType="pubmed">32690850</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi X, Keith KA, Huang JH. COVID-19 and stroke: A review. Brain Hemorrhages (2021) 2(2):76&#x2013;83. doi: 10.1016/j.hest.2020.11.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hest.2020.11.001</ArticleId><ArticleId IdType="pmc">PMC7670261</ArticleId><ArticleId IdType="pubmed">33225251</ArticleId></ArticleIdList></Reference><Reference><Citation>Sastry S, Cuomo F, Muthusamy J. COVID-19 and thrombosis: The role of hemodynamics. Thromb Res (2022) 212:51&#x2013;7. doi: 10.1016/j.thromres.2022.02.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2022.02.016</ArticleId><ArticleId IdType="pmc">PMC8864963</ArticleId><ArticleId IdType="pubmed">35219932</ArticleId></ArticleIdList></Reference><Reference><Citation>Olson JK, Miller SD. Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J Immunol (2004) 173(6):3916&#x2013;24. doi: 10.4049/jimmunol.173.6.3916</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.173.6.3916</ArticleId><ArticleId IdType="pubmed">15356140</ArticleId></ArticleIdList></Reference><Reference><Citation>von Zahn J, Moller T, Kettenmann H, Nolte C. Microglial phagocytosis is modulated by pro- and anti-inflammatory cytokines. Neuroreport (1997) 8(18):3851&#x2013;6. doi: 10.1097/00001756-199712220-00003</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00001756-199712220-00003</ArticleId><ArticleId IdType="pubmed">9462454</ArticleId></ArticleIdList></Reference><Reference><Citation>Badanjak K, Fixemer S, Smaji&#x107; S, Skupin A, Gr&#xfc;newald A. The contribution of microglia to neuroinflammation in parkinson&#x2019;s disease. Int J Mol Sci (2021) 22(9):4676. doi:&#xa0;10.3390/ijms22094676</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22094676</ArticleId><ArticleId IdType="pmc">PMC8125756</ArticleId><ArticleId IdType="pubmed">33925154</ArticleId></ArticleIdList></Reference><Reference><Citation>Muzio L, Viotti A, Martino G. Microglia in neuroinflammation and neurodegeneration: From understanding to therapy. Front Neurosci (2021) 15. doi: 10.3389/fnins.2021.742065</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2021.742065</ArticleId><ArticleId IdType="pmc">PMC8497816</ArticleId><ArticleId IdType="pubmed">34630027</ArticleId></ArticleIdList></Reference><Reference><Citation>Kulkarni A, Chen J, Maday S. Neuronal autophagy and intercellular regulation of homeostasis in the brain. Curr Opin Neurobiol (2018) 51:29&#x2013;36. doi: 10.1016/j.conb.2018.02.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.conb.2018.02.008</ArticleId><ArticleId IdType="pubmed">29529415</ArticleId></ArticleIdList></Reference><Reference><Citation>Leng F, Edison P. Neuroinflammation and microglial activation in Alzheimer disease: Where do we go from here? Nat Rev Neurol (2021) 17(3):157&#x2013;72. doi: 10.1038/s41582-020-00435-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-020-00435-y</ArticleId><ArticleId IdType="pubmed">33318676</ArticleId></ArticleIdList></Reference><Reference><Citation>Que Y, Hu C, Wan K, Hu P, Wang R, Luo J, et al. . Cytokine release syndrome in COVID-19: A major mechanism of morbidity and mortality. Int Rev Immunol (2022) 41(2):217&#x2013;30. doi: 10.1080/08830185.2021.1884248</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08830185.2021.1884248</ArticleId><ArticleId IdType="pmc">PMC7919105</ArticleId><ArticleId IdType="pubmed">33616462</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang L, Tang K, Levin M, Irfan O, Morris SK, Wilson K, et al. . COVID-19 and multisystem inflammatory syndrome in children and adolescents. Lancet Infect Diseases (2020) 20(11):e276&#x2013;e88. doi: 10.1016/S1473-3099(20)30651-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30651-4</ArticleId><ArticleId IdType="pmc">PMC7431129</ArticleId><ArticleId IdType="pubmed">32818434</ArticleId></ArticleIdList></Reference><Reference><Citation>Blatz AM, Randolph AG. Severe COVID-19 and multisystem inflammatory syndrome in children in children and adolescents. Crit Care Clinics (2022) 38(3):571&#x2013;86. doi:&#xa0;10.1016/j.ccc.2022.01.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccc.2022.01.005</ArticleId><ArticleId IdType="pmc">PMC8743385</ArticleId><ArticleId IdType="pubmed">35667744</ArticleId></ArticleIdList></Reference><Reference><Citation>Masi P, H&#xe9;kimian G, Lejeune M, Chommeloux J, Desnos C, Pineton De Chambrun M, et al. . Systemic inflammatory response syndrome is a major contributor to COVID-19-Associated coagulopathy: Insights from a prospective, single-center cohort study. Circulation (2020) 142(6):611&#x2013;4. doi: 10.1161/CIRCULATIONAHA.120.048925</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.048925</ArticleId><ArticleId IdType="pmc">PMC7418760</ArticleId><ArticleId IdType="pubmed">32776849</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei Y, Zhang J, Schiavon CR, He M, Chen L, Shen H, et al. . SARS-CoV-2 spike protein impairs endothelial function via downregulation of ACE 2. Circ Res (2021) 128(9):1323&#x2013;6. doi: 10.1161/CIRCRESAHA.121.318902</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.121.318902</ArticleId><ArticleId IdType="pmc">PMC8091897</ArticleId><ArticleId IdType="pubmed">33784827</ArticleId></ArticleIdList></Reference><Reference><Citation>Furuhashi M, Moniwa N, Takizawa H, Ura N, Shimamoto K. Potential differential effects of renin-angiotensin system inhibitors on SARS-CoV-2 infection and lung injury in COVID-19. Hypertension Res (2020) 43(8):837&#x2013;40. doi: 10.1038/s41440-020-0478-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41440-020-0478-1</ArticleId><ArticleId IdType="pmc">PMC7237878</ArticleId><ArticleId IdType="pubmed">32433641</ArticleId></ArticleIdList></Reference><Reference><Citation>del Valle-Mendoza J, Tarazona-Castro Y, Merino-Luna A, Carrillo-Ng H, Kym S, Aguilar-Luis MA, et al. . Comparison of cytokines levels among COVID-19 patients living at sea level and high altitude. BMC Infect Diseases (2022) 22(1):96. doi: 10.1016/j.ijid.2021.12.138</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.12.138</ArticleId><ArticleId IdType="pmc">PMC8795933</ArticleId><ArticleId IdType="pubmed">35090394</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulthei&#xdf; C, Willscher E, Paschold L, Gottschick C, Klee B, Henkes S-S, et al. . From online data collection to identification of disease mechanisms: The IL-1&#xdf;, IL-6 and TNF-&#x3b1; cytokine triad is associated with post-acute sequelae of COVID-19 in a digital research cohort. Cell Rep Med (2021) 3(6):100663. doi:&#xa0;10.1016/j.xcrm.2022.100663</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2022.100663</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Cosarderelioglu C, Nidadavolu LS, George CJ, Oh ES, Bennett DA, Walston JD, et al. . Brain renin-angiotensin system at the intersect of physical and cognitive frailty. Front Neurosci (2020) 14:586314&#x2013;. doi: 10.3389/fnins.2020.586314</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2020.586314</ArticleId><ArticleId IdType="pmc">PMC7561440</ArticleId><ArticleId IdType="pubmed">33117127</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright JW, Mizutani S, Harding JW. Focus on brain angiotensin III and aminopeptidase a in the control of hypertension. Int J Hypertension (2012) 2012:124758. doi: 10.1155/2012/124758</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/124758</ArticleId><ArticleId IdType="pmc">PMC3389720</ArticleId><ArticleId IdType="pubmed">22792446</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmer BF, Clegg DJ. Extrarenal effects of aldosterone on potassium homeostasis. Kidney360 (2022) 3(3):561. doi: 10.34067/KID.0006762021</Citation><ArticleIdList><ArticleId IdType="doi">10.34067/KID.0006762021</ArticleId><ArticleId IdType="pmc">PMC9034816</ArticleId><ArticleId IdType="pubmed">35582177</ArticleId></ArticleIdList></Reference><Reference><Citation>Pavo N, Prausm&#xfc;ller S, Spinka G, Goliasch G, Bartko PE, Wurm R, et al. . Myocardial angiotensin metabolism in end-stage heart failure. J Am Coll Cardiol (2021) 77(14):1731&#x2013;43. doi: 10.1016/j.jacc.2021.01.052</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2021.01.052</ArticleId><ArticleId IdType="pubmed">33832600</ArticleId></ArticleIdList></Reference><Reference><Citation>Cure E, Ilcol TB, Cumhur Cure M. III, and IV may be important in the progression of COVID-19. J Renin Angiotensin Aldosterone Syst (2020) 21(4):1470320320972019&#x2013;. doi: 10.1177/1470320320972019</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1470320320972019</ArticleId><ArticleId IdType="pmc">PMC7658520</ArticleId><ArticleId IdType="pubmed">33169633</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh KD, Jara ZP, Harford T, Saha PP, Pardhi TR, Desnoyer R, et al. . Novel allosteric ligands of the angiotensin receptor AT1R as autoantibody blockers. Proc Natl Acad Sci (2021) 118(33):e2019126118. doi: 10.1073/pnas.2019126118</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2019126118</ArticleId><ArticleId IdType="pmc">PMC8379978</ArticleId><ArticleId IdType="pubmed">34380734</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehrabadi ME, Hemmati R, Tashakor A, Homaei A, Yousefzadeh M, Hemati K, et al. . Induced dysregulation of ACE2 by SARS-CoV-2 plays a key role in COVID-19 severity. BioMed Pharmacother (2021) 137:111363&#x2013;. doi: 10.1016/j.biopha.2021.111363</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2021.111363</ArticleId><ArticleId IdType="pmc">PMC7862910</ArticleId><ArticleId IdType="pubmed">33582450</ArticleId></ArticleIdList></Reference><Reference><Citation>Kram&#xe1;r EA, Krishnan R, Harding JW, Wright JW. Role of nitric oxide in angiotensin IV-induced increases in cerebral blood flow. Regul Peptides (1998) 74(2):185&#x2013;92. doi: 10.1016/S0167-0115(98)00039-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0167-0115(98)00039-1</ArticleId><ArticleId IdType="pubmed">9712180</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang R, Walther T, Gembardt F, Smolders I, Vanderheyden P, Albiston AL, et al. . Renal vasoconstrictor and pressor responses to angiotensin IV in mice are AT1a-receptor mediated. J hypertension (2010) 28(3):487&#x2013;94. doi: 10.1097/HJH.0b013e3283343250</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/HJH.0b013e3283343250</ArticleId><ArticleId IdType="pubmed">19907343</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu H, Wu Y, Wang Q, Liu C, Xue L, Wang H, et al. . Effect of berberine on PPAR(&#x3b1;)-NO signalling pathway in vascular smooth muscle cell proliferation induced by angiotensin IV. Pharm Biol (2017) 55(1):227&#x2013;32. doi: 10.1080/13880209.2016.1257642</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13880209.2016.1257642</ArticleId><ArticleId IdType="pmc">PMC6130450</ArticleId><ArticleId IdType="pubmed">27927051</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen R, Wang K, Yu J, Howard D, French L, Chen Z, et al. . The spatial and cell-type distribution of SARS-CoV-2 receptor ACE2 in the human and mouse brains. Front Neurol (2021) 11. doi: 10.3389/fneur.2020.573095</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.573095</ArticleId><ArticleId IdType="pmc">PMC7855591</ArticleId><ArticleId IdType="pubmed">33551947</ArticleId></ArticleIdList></Reference><Reference><Citation>Manik M, Singh RK. Role of toll-like receptors in modulation of cytokine storm signaling in SARS-CoV-2-induced COVID-19. J Med Virol (2022) 94(3):869&#x2013;77. doi: 10.1002/jmv.27405</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27405</ArticleId><ArticleId IdType="pmc">PMC8662021</ArticleId><ArticleId IdType="pubmed">34672376</ArticleId></ArticleIdList></Reference><Reference><Citation>Bagheri-Hosseinabadi Z, Rezazadeh Zarandi E, Mirabzadeh M, Amiri A, Abbasifard M. mRNA expression of toll-like receptors 3, 7, 8, and 9 in the nasopharyngeal epithelial cells of coronavirus disease 2019 patients. BMC Infect Diseases (2022) 22(1):448. doi: 10.1186/s12879-022-07437-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-022-07437-9</ArticleId><ArticleId IdType="pmc">PMC9086663</ArticleId><ArticleId IdType="pubmed">35538443</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang M, Bergmann Cornelia C, Williams Bryan RG. Neuronal ablation of Alpha/Beta interferon (IFN-&#x3b1;/&#x3b2;) signaling exacerbates central nervous system viral dissemination and impairs IFN-&#x3b3; responsiveness in Microglia/Macrophages. J Virol (2020) 94(20):e00422&#x2013;20. doi: 10.1128/JVI.00422-20</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00422-20</ArticleId><ArticleId IdType="pmc">PMC7527041</ArticleId><ArticleId IdType="pubmed">32796063</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Wilson HL, Kiss-Toth E. Regulating STING in health and disease. J Inflammation (2017) 14(1):11. doi: 10.1186/s12950-017-0159-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12950-017-0159-2</ArticleId><ArticleId IdType="pmc">PMC5463399</ArticleId><ArticleId IdType="pubmed">28596706</ArticleId></ArticleIdList></Reference><Reference><Citation>Jamilloux Y, Henry T, Belot A, Viel S, Fauter M, El Jammal T, et al. . Should we stimulate or suppress immune responses in COVID-19? cytokine and anti-cytokine interventions. Autoimmun Rev (2020) 19(7):102567. doi: 10.1016/j.autrev.2020.102567</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2020.102567</ArticleId><ArticleId IdType="pmc">PMC7196557</ArticleId><ArticleId IdType="pubmed">32376392</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q, Bastard P, Liu Z, Le Pen J, Moncada-Velez M, Chen J, et al. . Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science (2020), 370(6515):eabd4570. doi: 10.1126/science.abd4570</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd4570</ArticleId><ArticleId IdType="pmc">PMC7857407</ArticleId><ArticleId IdType="pubmed">32972995</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernandez N, Bucciol G, Moens L, Le Pen J, Shahrooei M, Goudouris E, et al. . Inherited IFNAR1 deficiency in otherwise healthy patients with adverse reaction to measles and yellow fever live vaccines. J Exp Med (2019) 216(9):2057&#x2013;70. doi: 10.1084/jem.20182295</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20182295</ArticleId><ArticleId IdType="pmc">PMC6719432</ArticleId><ArticleId IdType="pubmed">31270247</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt A, Peters S, Knaus A, Sabir H, Hamsen F, Maj C, et al. . TBK1 and TNFRSF13B mutations and an autoinflammatory disease in a child with lethal COVID-19. NPJ Genomic Med (2021) 6(1):55. doi: 10.1038/s41525-021-00220-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41525-021-00220-w</ArticleId><ArticleId IdType="pmc">PMC8249618</ArticleId><ArticleId IdType="pubmed">34210994</ArticleId></ArticleIdList></Reference><Reference><Citation>Asano T, Boisson B, Onodi F, Matuozzo D, Moncada-Velez M, Maglorius Renkilaraj Majistor Raj L, et al. . X-Linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19. Sci Immunol (2021) 6(62):eabl4348. doi:&#xa0;10.1126/sciimmunol.abl4348</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abl4348</ArticleId><ArticleId IdType="pmc">PMC8532080</ArticleId><ArticleId IdType="pubmed">34413140</ArticleId></ArticleIdList></Reference><Reference><Citation>Fallerini C, Daga S, Mantovani S, Benetti E, Picchiotti N, Francisci D, et al. . Association of toll-like receptor 7 variants with life-threatening COVID-19 disease in males: Findings from a nested case-control study. eLife (2021) 10:e67569. doi:&#xa0;10.7554/eLife.67569</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.67569</ArticleId><ArticleId IdType="pmc">PMC7987337</ArticleId><ArticleId IdType="pubmed">33650967</ArticleId></ArticleIdList></Reference><Reference><Citation>Solanich X, Vargas-Parra G, van der Made CI, Simons A, Schuurs-Hoeijmakers J, Antol&#xed; A, et al. . Genetic screening for TLR7 variants in young and previously healthy men with severe COVID-19. Front Immunol (2021) 12:719115&#x2013;. doi:&#xa0;10.3389/fimmu.2021.719115</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.719115</ArticleId><ArticleId IdType="pmc">PMC8343010</ArticleId><ArticleId IdType="pubmed">34367187</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q, Bastard P, Karbuz A, Gervais A, Tayoun AA, Aiuti A, et al. . Human genetic and immunological determinants of critical COVID-19 pneumonia. Nature (2022) 603(7902):587&#x2013;98. doi:&#xa0;10.1038/s41586-022-04447-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04447-0</ArticleId><ArticleId IdType="pmc">PMC8957595</ArticleId><ArticleId IdType="pubmed">35090163</ArticleId></ArticleIdList></Reference><Reference><Citation>Heming M, Li X, R&#xe4;uber S, Mausberg AK, B&#xf6;rsch A-L, Hartlehnert M, et al. . Neurological manifestations of COVID-19 feature T cell exhaustion and dedifferentiated monocytes in cerebrospinal fluid. Immunity (2021) 54(1):164&#x2013;75.e6. doi:&#xa0;10.1016/j.immuni.2020.12.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2020.12.011</ArticleId><ArticleId IdType="pmc">PMC7831653</ArticleId><ArticleId IdType="pubmed">33382973</ArticleId></ArticleIdList></Reference><Reference><Citation>Ransohoff RM, Brown MA. Innate immunity in the central nervous system. J Clin Invest (2012) 122(4):1164&#x2013;71. doi: 10.1172/JCI58644</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI58644</ArticleId><ArticleId IdType="pmc">PMC3314450</ArticleId><ArticleId IdType="pubmed">22466658</ArticleId></ArticleIdList></Reference><Reference><Citation>Crunfli F, Carregari VC, Veras FP, Silva LS, Nogueira MH, Antunes ASLM, et al. . Morphological, cellular, and molecular basis of brain infection in COVID-19 patients. Proc Natl Acad Sci (2022) 119(35):e2200960119. doi: 10.1073/pnas.2200960119</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2200960119</ArticleId><ArticleId IdType="pmc">PMC9436354</ArticleId><ArticleId IdType="pubmed">35951647</ArticleId></ArticleIdList></Reference><Reference><Citation>Colonna M, Butovsky O. Microglia function in the central nervous system during health and neurodegeneration. Annu Rev Immunol (2017) 35(1):441&#x2013;68. doi: 10.1146/annurev-immunol-051116-052358</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-immunol-051116-052358</ArticleId><ArticleId IdType="pmc">PMC8167938</ArticleId><ArticleId IdType="pubmed">28226226</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutkai I, Mayer MG, Hellmers LM, Ning B, Huang Z, Monjure CJ, et al. . Neuropathology and virus in brain of SARS-CoV-2 infected non-human primates. Nat Commun (2022) 13(1):1745. doi: 10.1038/s41467-022-29440-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29440-z</ArticleId><ArticleId IdType="pmc">PMC8975902</ArticleId><ArticleId IdType="pubmed">35365631</ArticleId></ArticleIdList></Reference><Reference><Citation>Soltani Zangbar H, Gorji A, Ghadiri T. A review on the neurological manifestations of COVID-19 infection: A mechanistic view. Mol Neurobiol (2021) 58(2):536&#x2013;49. doi: 10.1007/s12035-020-02149-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-020-02149-0</ArticleId><ArticleId IdType="pmc">PMC7519857</ArticleId><ArticleId IdType="pubmed">32981023</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhodes R, Love G, Lameira F, Shahmirzadi M, Fox S, Vander Heide R. Reactive and acute inflammatory microvasculopathy in 36 COVID-19 autopsy brains. Res Sq (2022) 1&#x2013;24. doi: 10.21203/rs.3.rs-1619440/v1</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-1619440/v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasegawa S, Matsushige T, Inoue H, Shirabe K, Fukano R, Ichiyama T. Serum and cerebrospinal fluid cytokine profile of patients with 2009 pandemic H1N1 influenza virus-associated encephalopathy. Cytokine (2011) 54(2):167&#x2013;72. doi: 10.1016/j.cyto.2011.01.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2011.01.006</ArticleId><ArticleId IdType="pubmed">21371904</ArticleId></ArticleIdList></Reference><Reference><Citation>Paiva TM, Theotonio G, Paulino RS, Benega MA, Silva DBB, Borborema SET, et al. . (H3N2) strain isolated from cerebrospinal fluid from a patient presenting myelopathy post infectious. J Clin Virol (2013) 58(1):283&#x2013;5. doi: 10.1016/j.jcv.2013.05.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2013.05.021</ArticleId><ArticleId IdType="pubmed">23809474</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweetman LL, Y-t Ng, IJ B, Bodensteiner JB. Neurologic complications associated with respiratory syncytial virus. Pediatr neurol (2005) 32(5):307&#x2013;10. doi: 10.1016/j.pediatrneurol.2005.01.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pediatrneurol.2005.01.010</ArticleId><ArticleId IdType="pubmed">15866430</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawashima H, Kashiwagi Y, Ioi H, Morichi S, Oana S, Yamanaka G, et al. . Production of chemokines in respiratory syncytial virus infection with central nervous system manifestations. J Infection Chemother (2012) 18(6):827&#x2013;31. doi: 10.1007/s10156-012-0418-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10156-012-0418-3</ArticleId><ArticleId IdType="pubmed">22572852</ArticleId></ArticleIdList></Reference><Reference><Citation>Constant O, Barthelemy J, Nagy A, Salinas S, Simonin Y. West Nile Virus neuroinfection in humans: Peripheral biomarkers of neuroinflammation and neuronal damage. Viruses (2022) 14(4):756. doi: 10.3390/v14040756</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14040756</ArticleId><ArticleId IdType="pmc">PMC9027124</ArticleId><ArticleId IdType="pubmed">35458486</ArticleId></ArticleIdList></Reference><Reference><Citation>Kung P-L, Chou T-W, Lindman M, Chang NP, Estevez I, Buckley BD, et al. . Zika virus-induced TNF-&#x3b1; signaling dysregulates expression of neurologic genes associated with psychiatric disorders. J Neuroinflammation (2022) 19(1):100. doi: 10.1186/s12974-022-02460-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-022-02460-8</ArticleId><ArticleId IdType="pmc">PMC9036774</ArticleId><ArticleId IdType="pubmed">35462541</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarkowski E, Andreasen N, Tarkowski A, Blennow K. Intrathecal inflammation precedes development of alzheimer&#x2019;s disease. J Neurology Neurosurg Psychiatry (2003) 74(9):1200&#x2013;5. doi: 10.1136/jnnp.74.9.1200</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.74.9.1200</ArticleId><ArticleId IdType="pmc">PMC1738668</ArticleId><ArticleId IdType="pubmed">12933918</ArticleId></ArticleIdList></Reference><Reference><Citation>Brosseron F, Krauthausen M, Kummer M, Heneka MT. Body fluid cytokine levels in mild cognitive impairment and alzheimer&#x2019;s disease: A comparative overview. Mol Neurobiol (2014) 50(2):534&#x2013;44. doi: 10.1007/s12035-014-8657-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-014-8657-1</ArticleId><ArticleId IdType="pmc">PMC4182618</ArticleId><ArticleId IdType="pubmed">24567119</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouchi Y, Yoshikawa E, Sekine Y, Futatsubashi M, Kanno T, Ogusu T, et al. . Microglial activation and dopamine terminal loss in early parkinson's disease. Ann Neurol (2005) 57(2):168&#x2013;75. doi: 10.1002/ana.20338</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.20338</ArticleId><ArticleId IdType="pubmed">15668962</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojanathammanee L, Murphy EJ, Combs CK. Expression of mutant alpha-synuclein modulates microglial phenotype in vitro. J Neuroinflamm (2011) 8(1):44. doi: 10.1186/1742-2094-8-44</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-8-44</ArticleId><ArticleId IdType="pmc">PMC3104357</ArticleId><ArticleId IdType="pubmed">21554732</ArticleId></ArticleIdList></Reference><Reference><Citation>Umapathi T, Kor AC, Venketasubramanian N, Lim CCT, Pang BC, Yeo TT, et al. . Large Artery ischaemic stroke in severe acute respiratory syndrome (SARS). J Neurol (2004) 251(10):1227&#x2013;31. doi: 10.1007/s00415-004-0519-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-004-0519-8</ArticleId><ArticleId IdType="pmc">PMC7088071</ArticleId><ArticleId IdType="pubmed">15503102</ArticleId></ArticleIdList></Reference><Reference><Citation>Emmenegger M, Kumar SS, Emmenegger V, Malinauskas T, Buettner T, Rose L, et al. . Anti-prothrombin autoantibodies enriched after infection with SARS-CoV-2 and influenced by strength of antibody response against SARS-CoV-2 proteins. PloS Pathogens (2021) 17(12):e1010118. doi: 10.1371/journal.ppat.1010118</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1010118</ArticleId><ArticleId IdType="pmc">PMC8673606</ArticleId><ArticleId IdType="pubmed">34860860</ArticleId></ArticleIdList></Reference><Reference><Citation>Oxley TJ, Mocco J, Majidi S, Kellner CP, Shoirah H, Singh IP, et al. . Large-Vessel stroke as a presenting feature of covid-19 in the young. New Engl J Med (2020) 382(20):e60. doi: 10.1056/NEJMc2009787</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2009787</ArticleId><ArticleId IdType="pmc">PMC7207073</ArticleId><ArticleId IdType="pubmed">32343504</ArticleId></ArticleIdList></Reference><Reference><Citation>Juanes-Velasco P, Landeira Vi&#xf1;uela A L, Garc&#xed;a-Vaquero M, Lecrevisse Q, Herrero R, Ferruelo A, et al. . SARS-CoV-2 infection triggers auto-immune response in ARDS. Front Immunol (2022) 73. doi: 10.3389/fimmu.2022.732197</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.732197</ArticleId><ArticleId IdType="pmc">PMC8831226</ArticleId><ArticleId IdType="pubmed">35154090</ArticleId></ArticleIdList></Reference><Reference><Citation>Juanes-Velasco P, Landeira-Vi&#xf1;uela A, Acebes-Fernandez V, Hern&#xe1;ndez &#xc1;-P, Garcia-Vaquero ML, Arias-Hidalgo C, et al. . Deciphering human leukocyte antigen susceptibility maps from immunopeptidomics characterization in oncology and infections. Front Cell Infection Microbiol (2021) 11:642583. doi: 10.3389/fcimb.2021.642583</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2021.642583</ArticleId><ArticleId IdType="pmc">PMC8195621</ArticleId><ArticleId IdType="pubmed">34123866</ArticleId></ArticleIdList></Reference><Reference><Citation>Elkon K, Casali P. Nature and functions of autoantibodies. Nat Clin Pract Rheumatol (2008) 4(9):491&#x2013;8. doi: 10.1038/ncprheum0895</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncprheum0895</ArticleId><ArticleId IdType="pmc">PMC2703183</ArticleId><ArticleId IdType="pubmed">18756274</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xed;ez P, P&#xe9;rez-Andr&#xe9;s M, B&#xf8;gsted M, Azkargorta M, Garc&#xed;a-Valiente R, D&#xe9;gano RM, et al. . Dynamic intracellular metabolic cell signaling profiles during Ag-dependent b-cell differentiation. Front Immunol (2021) 12:637832. doi: 10.3389/fimmu.2021.637832</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.637832</ArticleId><ArticleId IdType="pmc">PMC8043114</ArticleId><ArticleId IdType="pubmed">33859640</ArticleId></ArticleIdList></Reference><Reference><Citation>Castanares-Zapatero D, Chalon P, Kohn L, Dauvrin M, Detollenaere J, Maertens de Noordhout C, et al. . Pathophysiology and mechanism of long COVID: A comprehensive review. Ann Med (2022) 54(1):1473&#x2013;87. doi: 10.1080/07853890.2022.2076901</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2022.2076901</ArticleId><ArticleId IdType="pmc">PMC9132392</ArticleId><ArticleId IdType="pubmed">35594336</ArticleId></ArticleIdList></Reference><Reference><Citation>Cervia C, Zurbuchen Y, Taeschler P, Ballouz T, Menges D, Hasler S, et al. . Immunoglobulin signature predicts risk of post-acute COVID-19 syndrome. Nat Commun (2022) 13(1):446. doi: 10.1038/s41467-021-27797-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-27797-1</ArticleId><ArticleId IdType="pmc">PMC8789854</ArticleId><ArticleId IdType="pubmed">35078982</ArticleId></ArticleIdList></Reference><Reference><Citation>Briquez PS, Rouhani SJ, Yu J, Pyzer AR, Trujillo J, Dugan HL, et al. . Severe COVID-19 induces autoantibodies against angiotensin II that correlate with blood pressure dysregulation and disease severity. Sci Adv (2022) 8(40):eabn3777. doi: 10.1126/sciadv.abn3777</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abn3777</ArticleId><ArticleId IdType="pmc">PMC9544317</ArticleId><ArticleId IdType="pubmed">36206332</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris SC, Gause WC, Finkelman FD. IL-4 suppression of in vivo T cell activation and antibody production. J Immunol (2000) 164(4):1734&#x2013;40. doi: 10.4049/jimmunol.164.4.1734</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.164.4.1734</ArticleId><ArticleId IdType="pubmed">10657618</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Bon A, Thompson C, Kamphuis E, Durand V, Rossmann C, Kalinke U, et al. . Cutting edge: Enhancement of antibody responses through direct stimulation of b and T cells by type I IFN. J Immunol (2006) 176(4):2074&#x2013;8. doi: 10.4049/jimmunol.176.4.2074</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.176.4.2074</ArticleId><ArticleId IdType="pubmed">16455962</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Bon A, Schiavoni G, D'Agostino G, Gresser I, Belardelli F, Tough DF. Type I interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. Immunity (2001) 14(4):461&#x2013;70. doi: 10.1016/S1074-7613(01)00126-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1074-7613(01)00126-1</ArticleId><ArticleId IdType="pubmed">11336691</ArticleId></ArticleIdList></Reference><Reference><Citation>Sathe A, Cusick JK. Biochemistry, immunoglobulin m. StatPearls: StatPearls Publishing; (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">32310455</ArticleId></ArticleIdList></Reference><Reference><Citation>Plomp R, Dekkers G, Rombouts Y, Visser R, Koeleman CAM, Kammeijer GSM, et al. . Hinge-region O-glycosylation of human immunoglobulin G3 (IgG3)*[S]. Mol Cell proteomics (2015) 14(5):1373&#x2013;84. doi: 10.1074/mcp.M114.047381</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/mcp.M114.047381</ArticleId><ArticleId IdType="pmc">PMC4424406</ArticleId><ArticleId IdType="pubmed">25759508</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhat NM, Kshirsagar MA, Bieber MM, Teng NNH. IgG subclasses and isotypes of VH4-34 encoded antibodies. Immunol investigations (2015) 44(4):400&#x2013;10. doi: 10.3109/08820139.2015.1015682</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/08820139.2015.1015682</ArticleId><ArticleId IdType="pubmed">25942350</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang SE, Feng A, Meng W, Apostolidis SA, Mack E, Artandi M, et al. . New-onset IgG autoantibodies in hospitalized patients with COVID-19. Nat Commun (2021) 12(1):1&#x2013;15. doi: 10.1038/s41467-021-25509-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-25509-3</ArticleId><ArticleId IdType="pmc">PMC8440763</ArticleId><ArticleId IdType="pubmed">34521836</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng A, Yang E, Moore A, Dhingra S, Chang S, Yin X, et al. . Autoantibodies targeting cytokines and connective tissue disease autoantigens are common in acute non-SARS-CoV-2 infections. Res Sq; (2022). doi:&#xa0;10.21203/rs.3.rs-1233038/v1</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-1233038/v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang JY, Roehrl MW, Roehrl VB, Roehrl MH. A master autoantigen-ome links alternative splicing, female predilection, and COVID-19 to autoimmune diseases. J Trans Autoimmunity (2022) 5:100147. doi: 10.1016/j.jtauto.2022.100147</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtauto.2022.100147</ArticleId><ArticleId IdType="pmc">PMC8872718</ArticleId><ArticleId IdType="pubmed">35237749</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. . Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in wuhan, China: A descriptive study. Lancet (2020) 395(10223):507&#x2013;13. doi: 10.1016/S0140-6736(20)30211-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30211-7</ArticleId><ArticleId IdType="pmc">PMC7135076</ArticleId><ArticleId IdType="pubmed">32007143</ArticleId></ArticleIdList></Reference><Reference><Citation>Asfuroglu Kalkan E, Ates I. A case of subacute thyroiditis associated with covid-19 infection. J endocrinological Invest (2020) 43(8):1173&#x2013;4. doi: 10.1007/s40618-020-01316-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40618-020-01316-3</ArticleId><ArticleId IdType="pmc">PMC7273820</ArticleId><ArticleId IdType="pubmed">32504458</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastard P, Rosen LB, Zhang Q, Michailidis E, Hoffmann H-H, Zhang Y, et al. . Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science (2020) 370(6515):eabd4585. doi: 10.1126/science.abd4585</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd4585</ArticleId><ArticleId IdType="pmc">PMC7857397</ArticleId><ArticleId IdType="pubmed">32972996</ArticleId></ArticleIdList></Reference><Reference><Citation>Dotan A, David P, Arnheim D, Shoenfeld Y. The autonomic aspects of the post-COVID19 syndrome. Autoimmun Rev (2022) 21(5):103071. doi: 10.1016/j.autrev.2022.103071</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2022.103071</ArticleId><ArticleId IdType="pmc">PMC8848724</ArticleId><ArticleId IdType="pubmed">35182777</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang EY, Mao T, Klein J, Dai Y, Huck JD, Jaycox JR, et al. . Diverse functional autoantibodies in patients with COVID-19. Nature (2021) 595(7866):283&#x2013;8. doi: 10.1038/s41586-021-03631-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03631-y</ArticleId><ArticleId IdType="pubmed">34010947</ArticleId></ArticleIdList></Reference><Reference><Citation>Khamsi R. Rogue antibodies could be driving severe COVID-19. Nature (2021) 590(7844):29&#x2013;31. doi: 10.1038/d41586-021-00149-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-021-00149-1</ArticleId><ArticleId IdType="pubmed">33469204</ArticleId></ArticleIdList></Reference><Reference><Citation>Saheb Sharif-Askari N, Saheb Sharif-Askari F, Ahmed SBM, Hannawi S, Hamoudi R, Hamid Q, et al. . Enhanced expression of autoantigens during SARS-CoV-2 viral infection. Front Immunol (2021) 12. doi: 10.3389/fimmu.2021.686462</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.686462</ArticleId><ArticleId IdType="pmc">PMC8278821</ArticleId><ArticleId IdType="pubmed">34276672</ArticleId></ArticleIdList></Reference><Reference><Citation>Burbelo PD, Iadarola MJ, Keller JM, Warner BM. Autoantibodies targeting intracellular and extracellular proteins in autoimmunity. Front Immunol (2021) 12. doi: 10.3389/fimmu.2021.548469</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.548469</ArticleId><ArticleId IdType="pmc">PMC7982651</ArticleId><ArticleId IdType="pubmed">33763057</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J, Rho J-h, Roehrl MH, Wang JY. Dermatan sulfate is a potential master regulator of IgH via interactions with pre-BCR, GTF2I, and BiP ER complex in pre-b lymphoblasts. bioRxiv (2021) 2021:01.18.427153. doi: 10.1101/2021.01.18.427153</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.01.18.427153</ArticleId><ArticleId IdType="pmc">PMC8185350</ArticleId><ArticleId IdType="pubmed">34113352</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang JY, Zhang W, Roehrl VB, Roehrl MW, Roehrl MH. An autoantigen atlas from human lung HFL1 cells offers clues to neurological and diverse autoimmune manifestations of COVID-19. Front Immunol (2022) 13. doi: 10.3389/fimmu.2022.831849</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.831849</ArticleId><ArticleId IdType="pmc">PMC8987778</ArticleId><ArticleId IdType="pubmed">35401574</ArticleId></ArticleIdList></Reference><Reference><Citation>van Eijk LE, Binkhorst M, Bourgonje AR, Offringa AK, Mulder DJ, Bos EM, et al. . COVID-19: immunopathology, pathophysiological mechanisms, and treatment options. J Pathol (2021) 254(4):307&#x2013;31. doi: 10.1002/path.5642</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.5642</ArticleId><ArticleId IdType="pmc">PMC8013908</ArticleId><ArticleId IdType="pubmed">33586189</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>